Distinct roles for p42/p44 and p38 mitogen-activated protein kinases in the induction of IL-2 by IL-1

Cytokine

Volumn 11, Issue 9, 1999, Pages 643-655

  Matthews, Jane S ^a   O'Neill, Luke A J ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

IL 1; MAP kinases; Signal transduction; T lymphocytes

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL CELL; ARTICLE; CELL LINE; CYTOKINE PRODUCTION; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SIGNAL TRANSDUCTION; THYMOMA;

EID: 0032867864     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1998.0478     Document Type: Article

References (62)

1. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood. 87:(1996);2095-2147.
2. O'Neill LAJ, Greene C. Signal transduction pathways activated by the IL1 receptor family: ancient signalling machinery in mammals insects and plants. J Leuk Biol. 63:(1998);650-657.
3. Bird TA, Sleath PR, deRoos PC, Dower SK, Virca GD. Interleukin-1 represents a new modality for the activation of extracellular signal-regulated kinases/microtubule-associated protein-2 kinases. J Biol Chem. 266:(1991);22661-22670.
4. Guy GR, Chua SP, Wong NS, Ng SB, Tan YH. Interleukin 1 tumour necrosis factor activate common multiple protein kinases in human fibroblasts. J Biol Chem. 266:(1991);14343-14352.
5. Saklatvala J, Rawlinson LM, Marshall CJ, Kracht M. Interleukin 1 and tumour necrosis factor activate the mitogen-activated protein (MAP) kinase kinase in cultured cells. FEBS Lett. 334:(1993);189-192.
6. Freshney NW, Rawlinson L, Guesdon F, Jones E, Cowley S, Hsuan J, Saklatvala J. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of hsp27. Cell. 78:(1994);1039-1049.
7. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, Davis RJ. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem. 270:(1995);7420-7426.
8. Jiang Y, Chen C, Li Z, Guo W, Gegner JA, Lin S, Han J. Characterisation of the structure and function of a new mitogen-activated protein kinase (p38β). J Biol Chem. 271:(1996);17920-17926.
9. Cuenda A, Cohen P, Buee-Scherrer V, Goedert M. Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J. 16:(1997);295-305.
10. Goedert M, Cuenda A, Craxton M, Jakes R, Cohen P. Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases. EMBO J. 16:(1997);3563-3571.
11. Kumar S, McDonnell PC, Gum RJ, Hand AT, Lee JC, Young PR. Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem Biophys Res Commun. 235:(1997);533-538.
12. Wang XS, Diener K, Manthey CL, Wang S, Rosenzweig B, Bray J, Delaney J, Cole CN, Chan-Hui P, Mantlo N, Lichenstein HS, Zukowski M, Yao Z. Molecular cloning and characterisation of a novel p38 mitogen-activated protein kinase. J Biol Chem. 272:(1997);23668-23674.
13. Jiang Y, Gram H, Zhao M, New L, Gu J, Feng L, Padova FD, Ulevitch RJ, Han J. Characterisation of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38δ J Biol Chem. 272:(1997);30122-30128.
14. Enslen H, Raingeaud J, Davis RJ. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J Biol Chem. 273:(1998);1741-1748.
15. Meier R, Rouse J, Cuenda A, Nebreda AR, Cohen P. Cellular stresses and cytokines activate multiple mitogen-activated protein kinase homologues in PC12 and KB cells. Eur J Biochem. 236:(1996);796-805.
16. Stein B, Brady H, Yang MX, Young DB, Barbosa MS. Cloning and characterisation of MEK6, a novel member of the mitogen-activated protein kinase knase cascade. J Biol Chem. 271:(1996);11427-11433.
17. Bird TA, Kyriakis JM, Tyshler L, Gayle M, Milne A, Virca GD. Interleukin-1 activates p54 mitogen-activated protein (MAP) kinase/stress-activated protein kinase by a pathway that is independent of p21ras, raf-1, and MAP kinase kinase. J Biol Chem. 269:(1994);31836-31844.
18. Lawler S, Cuenda A, Goedert M, Cohen P. SKK4, a novel activator of stress-activated protein kinase-1 (SAPK1/JNK). FEBS Lett. 414:(1997);153-158.
19. Finch A, Holland P, Cooper J, Saklatvala J, Kracht M. Selective activation of JNK/SAPK by interleukin-1 in rabbit liver is mediated by MKK7. FEBS Lett. 418:(1997);144-148.
20. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. A synthetic inhibitor of the mitogen-activated prtotein kinase cascade. Proc Natl Acad Sci U S A. 92:(1995);7686-7689.
21. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD98059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro andin vivo. J Biol Chem. 270:(1995);27489-27494.
22. Lee JC, Badger AM, Griswold DE, Dunnington D, Truneh A, Votta B, White JR, Young PR, Bender PE. Bicyclic imidazoles as a novel class of cytokine biosynthesis inhibitors. Ann NY Acad Sci. 696:(1993);149-170.
23. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW, Strickler JE, McLaughlin MM, Siemens IR, Fischer SM, Livi GP, White JR, Adams JL, Young PR. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature. 372:(1994);739-746.
24. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:(1995);229-233.
25. Wilson KP, McCaffrey PG, Hsiao K, Pazhanisamy S, Galullo V, Bemis GW, Fitzgibbon MJ, Caron PR, Murcko MA, Su MSS. The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase. Chem Biol. 4:(1997);423-431.
26. Young PR, McLaughlin MM, Kumar S, Kassis S, Doyle ML, McNulty D, Gallagher TF, Fisher S, McDonnell PC, Carr SA, Huddleston MJ, Seibel G, Porter TG, Livi GP, Adams JL, Lee JC. Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. J Biol Chem. 272:(1997);12116-12121.
27. Stricker K, Serfling E, Krammer PH, Falk W. An NFκB-like element plays an essential role in interleukin-1-mediated costimulation of the mouse interleukin-2 promoter. Eur J Immunol. 23:(1993);1475-1480.
28. El-Shemerly MYM, Besser D, Nagasawa M, Nagamine Y. 12-O-Tetradecanoylphorbol-13acetate activates the Ras/extracellular signal-regulated kinase (ERK) signaling pathway upstream of SOS involving serine phosphorylation of Shc in NIH3T3 cells. J Biol Chem. 272:(1997);30599-30602.
29. Janknecht R, Ernst WH, Pingoud V, Nordheim A. Activation of ternary complex factor Elk-1 by MAP kinases. EMBO J. 12:(1993);5097-5104.
30. Janknecht R, Ernst WH, Nordheim A. SAP1a is a nuclear target of signalling cascades involving ERKs. Oncogene. 10:(1995);1209-1216.
31. Whitehurst CE, Geppert TD. MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in T cells. J Immunol. 156:(1996);1020-1029.
32. Xing J, Ginty DD, Greenberg ME. Coupling of the Ras-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science. 273:(1996);959-963.
33. Serfling E, Avots A, Neumann M. The architecture of the interleukin-2 promoter: a reflection of T lymphocyte activation. Biochim Biophys Acta. 1263:(1995);181-200.
34. Serfling E, Barthelmas R, Pfeuffer I, Schenk B, Zarius S, Swoboda R, Mercurio F, Karin M. Ubiquitous and lymphocyte-specific factors are involved in the induction of the mouse interleukin 2 gene in T lymphocytes. EMBO J. 8:(1989);465-473.
35. Jain J, Valge-Archer VE, Rao A. Analysis of the AP1 sites in the IL-2 promoter. J Immunol. 148:(1992);1240-1250.
36. Cai Z, Korner M, Tarantino N, Chouaib S. IκBα overexpression in human breast carcinoma MCF7 cells inhibits nuclear factor-κB activation but not tumour necrosis factor-α-induced apoptosis. J Biol Chem. 272:(1997);96-101.
37. Berghe WV, Plaisance S, Boone E, Bosscher KD, Schmitzf ML, Fiers W, Haegeman G. p38 and Extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-κB p65 transactivation mediated by tumour necrosis factor. J Biol Chem. 273:(1998);3285-3290.
38. Muegge K, Wiliams TM, Kant J, Karin M, Chiu R, Schmidt A, Siebenlist U, Young HA, Durum SK. Interleukin-1 costimulatory activity on the interleukin-2 promoter via AP-1. Science. 246:(1989);249-251.
39. Dumont FJ, Staruch MJ, Fischer P, DaSilva C, Camacho R. Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signalling pathways results in differential modulation of cytokine production. J Immunol. 160:(1998);2579-2589.
40. Matsuda S, Moriguchi T, Koyasu S, Nishida E. T Lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK/JNK signalling pathways sensitive to cyclosporin A. J Biol Chem. 273:(1998);12378-12382.
41. Cavigelli M, Dolfi F, Claret F, Karin M. Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. EMBO J. 14:(1995);5957-5964.
42. Gille H, Strahl T, Shaw PE. Activation of ternary complex factor Elk-1 by stress-activated protein kinases. Curr Biol. 5:(1995);1191-1200.
43. Whitmarsh AJ, Shore P, Sharrocks AD, Davis RJ. Integration of MAP kinase signal transduction pathways at the serum response element. Science. 269:(1995);403-407.
44. Young P, McDonnell P, Dunnington D, Hand A, Laydon J, Lee J. Pyridinyl imidazoles inhibit IL1 and TNF production at the protein level. Agents Actions. 39:(1993);C67-C69.
45. Pritchett W, Hand A, Shields J, Dunnington D. Mechanism of action of bicyclic imidazoles defines a translational regulatory pathway for tumour necrosis factor alpha. J Inflamm. 45:(1995);97-105.
46. Pietersma A, Tilly BC, Gaestel M, de Jong N, Lee JC, Koster JF, Sluiter W. p38 Mitogen activated protein kinase regulates endothelial VCAM-1 expression at the post-transcriptional level. Biochem Biophys Res Commun. 230:(1997);44-48.
47. Ridley SH, Sarsfield SJ, Lee JC, Bigg HF, Cawston TE, Taylor DJ, DeWitt DL, Saklatvala J. Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase. J Immunol. 158:(1997);3165-3173.
48. Da Silva J, Pierrat B, Mary J-L, Lesslauer W. Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes. J Biol Chem. 272:(1997);28373-28380.
49. Bhat NR, Zhang P, Lee JC, Hogan EL. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumour necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J Neurosci. 18:(1998);1633-1641.
50. Larsen CM, Wadt KAW, Juhl LF, Andersen HU, Karlsen AE, Su MSS, Seedorf K, Shapiro L, Dinarello CA, Mandrup-Poulsen T. Interleukin-1 β-induced rat pancreatic islet nitric oxide synthesis requires both the p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J Biol Chem. 273:(1998);15294-15300.
51. Beyaert R, Cuenda A, Berghe WV, Plaisance S, Lee JC, Haegeman G, Cohen P, Fiers W. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumour necrosis factor. EMBO J. 15:(1996);1914-1923.
52. Wesselborg S, Bauer MKA, Vogt M, Schmitz ML, Schulze-Osthoff K. Activation of transcription factor NF-κB and p38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways. J Biol Chem. 272:(1997);12422-12429.
53. Bergmann M, Hart L, Lindsay M, Barnes PJ, Newton R. IκBα degradation and nuclear factor-κB DNA binding are insufficient for interleukin-1β and tumour necrosis factor-α-induced κB-dependent transcription. J Biol Chem. 273:(1998);6607-6610.
54. Chen C, Gatto-Konczak FD, Wu Z, Karin M. Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. Science. 280:(1998);1945-1949.
55. Morley S, McKendrick L. Involvement of stress-activated protein kinase and p38/RK mitogen-activated protein kinase signalling pathways in the enhanced phosphorylation of initiation factor 4E in NIH 3T3 cells. J Biol Chem. 272:(1997);17887-17893.
56. Waskiewicz AJ, Flynn A, Proud CG, Cooper JA. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J. 16:(1997);1909-1920.
57. Haystead TAJ, Haystead CMM, Hu C, Lin T, Lawrence JC. Phosphorylation of PHAS-1 by mitogen-activated protein (MAP) kinase. J Biol Chem. 269:(1994);23185-23191.
58. Pause A, Belsham GJ, Gingras A, Donze O, Lin T, Lawrence JC, Sonenberg N. Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5′-cap function. Nature. 371:(1994);762-767.
59. Wang X, Flynn A, Waskiewicz AJ, Webb BLJ, Vries RG, Baines IA, Cooper JA, Proud CG. The phosphorylation of eukaryotic initiation factor eIF4E in response to phorbol esters, cell stresses, and cytokines is mediated by distinct MAP kinase pathways. J Biol Chem. 273:(1998);9373-9377.
60. 2biosynthesis stimulated by interleukin-1β J Biol Chem. 272:(1997);8083-8089.
61. Brennan P, O'Neill LAJ. Effects of oxidants and antioxidants on nuclear factor kB activation in three different cell lines: evidence against a universal hypothesis involving oxygen radicals. Biochim Biophys Acta. 1260:(1995);167-175.
62. Moynagh PN, Williams DC, O'Neill LAJ. Interleukin-1 activates transcription factor NFκB in glial cells. Biochem J. 294:(1993);343-347.